Single Agent Rituximab Active in Nodular Lymphocyte Predominant Hodgkin Lymphoma
Journal of Clinical Oncology (JCO) Podcast · Journals Online Team
February 10, 20146m 41s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This podcast describes the recent experience of single agent rituximab as management for newly diagnosed and relapsed nodular lymphocyte predominant Hodgkin lymphoma. The podcast includes a summary of the trial and discussion of the implications of the findings that rituximab has activity in both the upfront and relapsed setting.